{"id":"W3134421833","doi":"10.1002/cncr.33487","title":"Differential treatment outcomes in <i>BRCA1/2</i>‐, <i>CDK12</i>‐, and <i>ATM</i>‐mutated metastatic castration‐resistant prostate cancer","year":2021,"lang":"en","type":"article","venue":"Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; University of British Columbia; University of Calgary","funders":"Astellas Pharma; Endocyte; Mirati Therapeutics; Giannini Foundation of Agricultural Economics; Sanofi; Genentech; AstraZeneca; Daiichi Sankyo Europe; Bristol-Myers Squibb; Pfizer; A.P. Giannini Foundation","keywords":"Enzalutamide; Medicine; Docetaxel; Cabazitaxel; Prostate cancer; Carboplatin; Oncology; Internal medicine; Chemotherapy; Abiraterone; Population; Cancer; Androgen deprivation therapy; Androgen receptor; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005137028,0.0001181388,0.0002653697,0.0003574426,0.0002053569,0.0003935341,0.000195643,0.0002124433,0.0009933846],"category_scores_gemma":[0.001850641,0.0000774837,0.0003617781,0.0003817738,0.0001862293,0.0002160161,0.0002735513,0.0003089743,0.00008997315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004481633,"about_ca_system_score_gemma":0.0003012085,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001406868,"about_ca_topic_score_gemma":0.002743477,"domain_scores_codex":[0.9996583,0.0001088231,0.00003166687,0.00007307728,0.00005615484,0.00007196862],"domain_scores_gemma":[0.9989498,0.0002692286,0.0005216227,0.00003093191,0.00005215026,0.0001763238],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008160382,0.0000631867,0.9913003,0.00002334769,0.00008443172,0.0001671633,0.00008067994,0.0002677026,0.0005811112,0.00003795455,0.0001316039,0.006446494],"study_design_scores_gemma":[0.00002782813,0.0004529301,0.9976165,0.000008976183,0.00005995258,0.0007097243,0.0001099429,0.0004516493,0.000279872,0.00008237649,0.0001957736,0.000004571658],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992805,0.0003245586,0.00005695134,0.00002817586,0.000002184924,0.000003383808,0.0001057756,0.000001944913,0.0001965904],"genre_scores_gemma":[0.999787,0.00004319347,0.00001818323,0.00001035108,0.000002499554,0.000001774181,0.000114194,7.263788e-7,0.00002199829],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001406868,"threshold_uncertainty_score":0.003323138,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03828403333267071,"score_gpt":0.3555879666234552,"score_spread":0.3173039332907844,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}